EDAP, based in Lyon, France, now has FDA clearance to bring to the U.S. its Focal One high intensity focused ultrasound system. It’s used to ablate prostate tissue in a non-invasive way, relying on sound waves to resonate tissue apart at the cellular level.
A urologist, using the system, combines imagery from previously obtained MRI scans and 3D biopsy data, to overlay on the live ultrasound scan obtained by the system. Once the target region is confirmed and the outlines are contoured, the high intensity sound beam is directed at the tissue to ablate it. It avoids what’s outside the drawn contours and only attacks what’s within.
“Focal One is a great step forward in using this new and important ultrasound technology for prostate tissue ablation,” said Dr. Brian Miles, Urologist, Professor of Urology, Houston Methodist Hospital – Weill Cornell Medical College. “Focal One’s ability to merge MRI images, ultrasound images and biopsy data in order to precisely outline and treat just the diseased tissue area of the prostate is truly remarkable.”
We at Medgadget appreciate the clog selection of the physician at the controls in the image above.
Product page: Focal One…
Via: EDAP…
